Atlas Trials

A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer

Clinical trial NCT01163929 · WITHDRAWN

Trial details

NCT number
NCT01163929
Sponsor
University of Kansas
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2010-07-01
Primary completion
2012-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.